Apoptosis in peripheral neuroblastic tumors. Immunohistochemical expression of bcl-2 and p53 is related to DNA fragmentation

Histology and Histopathology

Volumn 22, Issue 10-12, 2007, Pages 1365-1370

  Mejía, Carmen ^a   Navarro, S ^b   Llombart Bosch, A ^b  

^a INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Apoptosis in situ; Biochemical apoptosis; Neuroblastoma

Indexed keywords

AVIDIN; BIOTIN; DNA FRAGMENT; PEROXIDASE; PROTEIN BCL 2; PROTEIN P53; TP53 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROPHORESIS; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RISK FACTOR; SOUTHERN BLOTTING; BIOSYNTHESIS; CHEMISTRY; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; PATHOLOGY; TUMOR SUPPRESSOR GENE;

APOPTOSIS; AVIDIN; BIOTIN; DNA FRAGMENTATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; PEROXIDASES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34748887730     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bissonnette R., Echeverri F., Mahoubi A. and Green D. (1992). Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359, 552-554.
2. Brodeur J.M., Seeger R.C. and Barret A. (1988). International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. J. Clin. Oncol. 6, 1874-1881.
3. Castel V., Cañete A. and García-Miguel P. (1995). Change in age and stage distribution of neuroblastoma patients in Spain. Localized Neuroblastoma and 4th International Symposium on Neuroblastoma Screening, Stuttgart, Germany (abs 25).
4. Castel V., García-Miguel P., Melero C., Navajas A., Navarro S., Molina J., Badal M.D., Ruiz-Jimenez J. on behalf of the Spanish Neuroblastoma Study Group. (1995). The treatment of advanced neuroblastoma. Results of the Spanish Neuroblastoma Study Group (SNSG) studies. Eur. J. Cancer 4, 642-645.
5. Castle V., Kathleen P., Bromberg J., Ou X., Dole M. and Nuñez G (1990). Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavourable histology and N-myc amplification. Am. J. Pathol. 143, 1543-1550.
6. Cattoretti G., Pileri S., Parraviccini C., Becker M., Poggi S., Biulco C., Key G., D'Amato L., Sabattini E., Feudale E., Reynolds F., Gerde J. and Rilke F. (1993). Antigen unmasked on formalin-fixed, paraffin-embedded tissue sections. J. Pathol. 171, 83-98.
7. Cohen G.M., Sun X.M., Snowden R.T., Ormerod M.G. and Dinsdale D. (1993). Identification of a transitional preapoptotic population of thymocytes. J. Immunol. 151, 566-574. Erratum in: J. Immunol. 151, 6616.
8. Crabbe D.C.G., Peters J. and Seeger R.C. (1992). Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. Diag. Mol. Pathol. 1, 229-234.
9. Gavrieli Y., Sherman Y. and Ben-Sasson S.A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
10. Gorczyca W., Gong J. and Darzynkiewicz Z. (1993). Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53, 1945-1951.
11. Hanada M., Krajewski S., Tanaka S., Cazals-Hatem D., Spengler B., Ross R., Biedler J. and Reed J. (1993). Regulation of bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res. 53, 4978-4986.
12. Hollstein M., Shomer B., Greenblatt M., Soussi T., Having E., Montesano R. and Harris C.C. (1996). Somatic point mutations in the p53 gene of human tumors and cell lines: update compilation. Nucl. Acid Res. 24, 141-146.
13. Hsu S.M., Raine L. and Fanger H. (1981). Use of avidin-biotin-peroxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577-580.
14. Knudson C.M., Tung K.S.K., Tourtellotte W.G., Brown G.A. and Korsmeyer S.J. (1995). Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96-99.
15. Look T., Hayes A., Shuster J., Douglas E., Castleberry R., Bowman L., Smith E. and Brodeur G. (1991). Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J. Clin. Oncol. 9, 581-591.
16. Matsumura M., Tsunoda A., Nishi T. and Nishihira H. (1991). Spontaneous regression of neuroblastoma detetcted by mass screening. Comment on: Lancet 337, 344-346.
17. Mejia C., Navarro S., Pellín A., Castel V. and Llombart-Bosch A. (1998). Study of bcl-2 protein expression and the apoptosis phenomenon in neuroblastoma. Anticancer Res. 18, 801-806.
18. Mejia C., Pellín A., Navarro S., Castel V. and Llombart-Bosch A. (1999). A new mutation of the p53 gene in human neuroblastoma, not correlated with N-myc amplification. Int. J. Surg. Pathol. 7, 149-153.
19. Mejia M.C., Navarro S., Pellin A., Ruiz A., Castel V. and Llombart-Bosch A. (2002). Study of proliferation and apoptosis in neuroblastoma. Their relation with other prognostic factors. Arch. Med. Res. 33, 466-472.
20. Navarro S., Amann G., Beiske K., Cullinane C.J., d'Amore E.S., Gambini C., Mosseri V., De Bernardi B., Michon J. and Peuchmaur M. (2006). European Study Group 94.01 Trial and Protocol. Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathalogic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol. J. Clin. Oncol. 24, 695-699.
21. Nigro J.M., Baker S.J., Preisinger A., Jessup J., Hostetter R., Cleary K., Bigner S., Davidson N., Baylin S., Devilee P., Glovert T., Collins F.C., Weslon A., Modali R., Harris C.C. and Vogelstein B. (1989). Mutations in the p53 gene occur in diverse human tumor types. Nature 342, 705-708.
22. Norusis M. (1994). SPSS Base para Windows. Versión 10.0. Guía del Usuario. SPSS Inc. USA. pp 333.
23. Peuchmaur M., d'Amore E.S., Joshi VV., Hata J., Roald B., Dehner L.P., Gerbing R.B., Strain D.O., Lukens J.N., Matthay K.K. and Shimada H. (2003). Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer 98, 2274-2281.
24. Rudolph P., Lappe T., Hero B., Berthold F., Parwaresch R., Harms D. and Schmidt D. (1993). Prognostic significance of the proliferative activity in neuroblastoma. Am. J. Pathol. 150, 133-145.
25. Saito T., Tsunematsu V., Saeki M., Honna T., Masaki E., Kojima Y. and Miyauchi J. (1997). Trends of survival in neuroblastoma and independent risk factors for survival at a single institution. Med. Pediatr. Oncol. 29, 197-205.
26. Sambrook J., Fritsch E.F. and Maniatis T. (1989). Analysis of genomic DNA Southern hybridization. In: Molecular cloning: a laboratory manual. Nolan C., Ford N. and Ferguson M. (eds). Cold Spring Harbor, Lab Press. New York, NY. pp 342-345.
27. Schleiermacher G., Peter M., Michon J., Hugot J., Vielh P., Zucker J., Magdelénat H., Thomas G. and Delaterre O. (1994). Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer 10, 275-281.
28. Schott A.F., Apel I.J., Nuñez G. and Clarke M.F. (1995). Bcl-xL protects cancer cells from p53-mediated apoptosis. Oncogene 11, 1389-1394.
29. Schwab M., Varmus H.E. and Bishop J.M. (1994). Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature 308, 288-293.
30. Weinreb M., Day P.J.R., Niggli F., Raafat F. and Mann J. (1995). BCL-2 oncoprotein in neuroblastoma. Lancet 345, 992-993.